Patent intelligence · US
US 11566255
Expression of PEDV sequences in plants and plant produced vaccine for same
Expression of PEDV sequences in plants and plant produced vaccine for same
Patent details — US 11566255
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 31, 2023
- Expiration
- Jan 26, 2043
- Applicant
- Mazen Animal Health, Inc.
- Claims
- 18
- CPC classes
- A61K, A61K38/162, A61K39/12, A61K39/225
Quick answer
US 11566255 (Expression of PEDV sequences in plants and plant produced vaccine for same) is held by Mazen Animal Health, Inc.. Status: granted. Granted Jan 31, 2023. Expires Jan 26, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Mazen Animal Health, Inc.
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K38/162, A61K39/12, A61K39/225, A61P, A61P31/14
More from Mazen Animal Health, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12310943
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12297182
Compositions comprising an urolithin compound
granted -
US 12226455
Medical composition for treating cardiac wasting and cachexia
granted -
US 12220424
Compositions comprising nicotinamide riboside and a urolithin
granted -
US 12109190
Urolithins as immune response enhancers
granted -
US 12036205
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12030863
Prodrugs of urolithins and uses thereof
granted -
US 11969408
Method for improving mitophagy in subjects
granted
Frequently asked questions
What is US patent 11566255?
US 11566255 (Expression of PEDV sequences in plants and plant produced vaccine for same) is held by Mazen Animal Health, Inc.. Status: granted. Granted Jan 31, 2023. Expires Jan 26, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11566255?
Mazen Animal Health, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 60 pharmaceutical patents for this assignee.
When does US 11566255 expire?
Our index shows an expiration date of Jan 26, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.